Overview

Effect of Obesity on Cyclosporine Blood Trough Level in Nephrotic Syndrome Patients

Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
This study aims to assess the effect of obesity on therapeutic response and safety of cyclosporine trough level in nephrotic syndrome patients and calculating a suitable weight-based dose.
Phase:
Phase 4
Details
Lead Sponsor:
Alexandria University
Treatments:
Cyclosporine
Cyclosporins